We are live on
!
Find out more
IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.89B
1-Year Est. Return
118.48%
This Fund
S&P 500
1 Year Est. Return
+118.48%
AUM
$1.89B
AUM Growth
-$83.2M
(-4.2%)
Holding
110
Top Buys
| 1 | +$38.4M | |
| 2 | +$30.3M | |
| 3 | +$29.5M | |
| 4 |
Boston Scientific
BSX
|
+$26M |
| 5 |
Merck
MRK
|
+$20.2M |
Top Sells
| 1 | +$64.8M | |
| 2 | +$37.9M | |
| 3 | +$31.2M | |
| 4 |
Penumbra
PEN
|
+$31.1M |
| 5 |
Teleflex
TFX
|
+$30.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$20.4B
| $245M | 12.98% |
1,500,000
+250,000
|
|
||
2
Revolution Medicines
RVMD
$31.6B
| $146M | 7.72% |
1,500,000
+300,000
|
|
||
3
Cytokinetics
CYTK
$9.22B
| $105M | 5.58% |
1,600,000
+200,000
|
|
||
4
Regeneron Pharmaceuticals
REGN
$64.1B
| $65.7M | 3.48% |
85,000
-20,000
|
|
||
5
Vera Therapeutics
VERA
$2.28B
| $64.4M | 3.41% |
1,600,000
-200,000
|
|
||
6
Cardinal Health
CAH
$47.9B
| $57.1M | 3.02% |
270,000
+70,000
|
|
||
7
Roivant Sciences
ROIV
$20.5B
| $55.4M | 2.93% |
2,000,000
+1,150,000
|
|
||
8
BrightSpring Health Services
BTSG
$11.6B
| $53.3M | 2.82% |
1,250,000
+500,000
|
|
||
9
Rhythm Pharmaceuticals
RYTM
$5.89B
| $52.2M | 2.76% |
600,000
+125,000
|
|
||
|
10
Merck
MRK
$295B
| $51.1M | 2.71% |
425,000
+175,000
|
|
||
11
Edgewise Therapeutics
EWTX
$3.75B
| $50.4M | 2.67% |
1,600,000
+100,000
|
|
||
12
AstraZeneca
AZN
$282B
| $49.3M | 2.61% |
250,000
-100,000
|
|
||
13
Alignment Healthcare
ALHC
$3.17B
| $45.4M | 2.4% |
2,575,000
+375,000
|
|
||
14
Novartis
NVS
$279B
| $38.2M | 2.02% |
250,000
|
|
||
|
15
Boston Scientific
BSX
$72.4B
| $34.5M | 1.83% |
550,000
+325,000
|
|
||
16
Lifestance Health
LFST
$2.8B
| $27.4M | 1.45% |
4,300,000
+1,300,000
|
|
||
17
Ascendis Pharma A/S
ASND
$12.7B
| $26.3M | 1.39% |
115,000
+25,000
|
|
||
18
Scholar Rock
SRRK
$5.25B
| $24.6M | 1.3% |
500,000
+200,000
|
|
||
19
Elevance Health
ELV
$90.8B
| $22M | 1.16% |
75,000
+15,000
|
|
||
20
Centene
CNC
$32.1B
| $21.3M | 1.13% |
650,000
|
|
||
21
BridgeBio Pharma
BBIO
$13.2B
| $20.4M | 1.08% |
+275,000
|
|
||
22
Mineralys Therapeutics
MLYS
$1.98B
| $20.3M | 1.08% |
750,000
|
|
||
23
Neurocrine Biosciences
NBIX
$16.4B
| $19.8M | 1.05% |
150,000
|
|
||
24
Glaukos
GKOS
$7.16B
| $18.8M | 1% |
175,000
-150,000
|
|
||
25
Arrowhead Research
ARWR
$10.4B
| $18.8M | 1% |
300,000
+200,000
|
|